Photo: Mikal Schlosser

DTU appoints Head of DTU Health Technology

Tuesday 02 Apr 19


Anders Overgaard Bjarklev
+45 45 25 10 00


Thomas Lars Andresen
Head of department, professor
DTU Health Tech
+45 25 37 44 86
Professor Thomas Andresen will become the new Head of Department of the newly created DTU Health Technology. (This story has been updated)

Update: Professor Thomas Andresen has resigned as head of department at DTU Health Technology for personal reasons as of April 26, 2019. Head of department Jørgen Schøller is acting as head of department.

With effect from 1 April, Professor Thomas Andresen has been appointed Head of the new department DTU Health Technology.

Since April 2018, Thomas Andresen has lived and worked in Boston as Chief Scientific Officer in the pharmaceutical company Torque Therapeutics, of which he was one of the founders in 2015. In the period 2016-2018, he was Head of Department of the then DTU Nanotech.

“Thomas is a highly competent, hard-working, and ambitious researcher, as well as an innovative pioneer. He has some very clear visions in the field of health technology, and I’m therefore convinced that he is completely the right person to head DTU’s new commitment to health technology,” says Anders Bjarklev in connection with the appointment.

The new Head of Department’s expertise lies within drug delivery, i.e. systems for delivering immunostimulatory molecules to cancer patients’ own immune cells and programming them to recognize cancer cells.

“I hope to be able to contribute to making the new department internationally renowned for its research, teaching, and innovation in health technology. We must create a culture in which the employees are proud of their workplace and perform their tasks with professionalism, commitment, and a desire to make a difference to society and people. As a department, we must measure our performance in terms of creating results which outlive us, and where the belief that we make a difference is an integral part of our motivation,” says Thomas Andresen.

On the basis of his research, Thomas Andresen has participated in founding the companies Nanovi, X-Therapeutics, Monta Biosciences, and Torque Therapeutics.

Throughout his career, he has received several awards for his research, including an EliteForsk prize of DKK 1.2 million, an ERC Starting Grant, and one of the prestigious Sapere Aude DFF Advanced Grants from the Danish Council for Independent Research.


Born: 12 October 1972 in Copenhagen

Co-founder of the companies Nanovi, X-Therapeutics, Monta Biosciences, and Torque Therapeutics.

Prizes and grants: Sapere Aude DFF Advanced Grant, ERC StG, Elite Researcher, NNF Challenge Center, Lundbeck Fellow.

2018: CSO Torque

2016: Head of DTU Nanotech

2014: Deputy Director and Acting Head of Department, DTU Nanotech

2012: Professor of Chemistry and Biomaterials, DTU

2007: Associate Professor of Chemistry and Biomaterials, DTU

2005: PhD degree from DTU

2001-2007: Research Director, LiPlasome Pharma

1994-1996: Software Developer, Danmarks Radio

2001: MSc Eng from DTU and the University of Auckland, New Zealand.